HCAT
Health Catalyst Inc
1.80$
-0.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 57.3% | 56.1% | 57.1% | 54.4% | 56.3% | 54.2% | 47.4% | 29.3% | 28.2% | 33.7% | 44.2% | 69.3% | |
| 13.3% | 15.1% | 29.0% | 29.2% | 40.4% | 29.1% | 38.4% | 8.2% | 6.9% | 10.1% | 14.5% | 16.9% | |
| 48.8% | 45.3% | 47.2% | 44.6% | 47.6% | 45.6% | 38.4% | 15.8% | 15.6% | 19.0% | 26.4% | 28.8% | |
| 6.5% | 8.6% | 7.8% | 7.9% | 6.4% | 6.7% | 7.2% | 11.1% | 10.2% | 11.8% | 14.3% | 11.7% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 26.1% | 27.2% | 27.4% | 29.8% | 28.8% | 30.2% | 35.2% | 46.4% | 48.6% | 41.6% | 27.5% | 3.1% | |
| 10.1% | 10.5% | 9.5% | 9.7% | 9.4% | 10.0% | 11.9% | 16.0% | 15.3% | 15.5% | 16.8% | 15.6% | |
| 46.4% | 47.7% | 48.6% | 48.4% | 56.3% | 57.5% | 57.7% | 43.6% | 43.5% | 51.1% | 66.5% | 71.9% | |
| 11.8% | 12.7% | 13.3% | 46.0% | 39.8% | 37.9% | 38.1% | 16.0% | 15.0% | 17.8% | 26.1% | 25.6% | |
| 0.5% | 0.5% | 0.5% | 33.6% | 28.8% | 27.3% | 26.4% | 0.9% | 0.9% | 1.1% | 1.3% | 1.5% | |
| 0.9% | 0.9% | 0.8% | 1.5% | 1.8% | 1.3% | 1.0% | 1.5% | 0.8% | 1.9% | 2.8% | 2.3% | |
| 31.9% | 32.5% | 32.9% | – | 14.1% | 17.6% | 17.0% | 24.6% | 25.8% | 30.2% | 36.8% | 42.3% | |
| 53.6% | 52.3% | 51.4% | 51.6% | 43.7% | 42.5% | 42.3% | 56.4% | 56.5% | 48.9% | 33.5% | 28.1% | |
| -152.5% | -159.2% | -163.7% | -166.4% | -143.4% | -138.2% | -135.8% | -203.1% | -216.9% | -271.5% | -358.0% | -422.8% | |
| 8.0% | 8.2% | 8.4% | 8.6% | 7.4% | 7.3% | 7.7% | 11.3% | 12.0% | 14.1% | 17.6% | 20.6% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.